Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Dec 26, 2020; 12(12): 599-614
Published online Dec 26, 2020. doi: 10.4330/wjc.v12.i12.599
Published online Dec 26, 2020. doi: 10.4330/wjc.v12.i12.599
Diagnostic and prognostic value of cardiac imaging in amyloidosis
Rafael Vidal-Perez, Alberto Bouzas-Mosquera, Servicio de Cardiología, Unidad de Imagen y Función Cardíaca, Complexo Hospitalario Universitario A Coruña (CHUAC), Santiago de Compostela 15706, A Coruña, Spain
Raquel Vázquez-García, Rafaela Soler-Fernandez, Jose Maria Larrañaga-Moreira, Jose Manuel Vazquez-Rodriguez, Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña (CHUAC), A Coruña 15006, A Coruña, Spain
Gonzalo Barge-Caballero, Maria Generosa Crespo-Leiro, Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña, Unidad de Insuficiencia Cardiaca Avanzada y Trasplante Cardiaco, Instituto de Investigación Biomédica de A Coruña (INIBIC), Centro de Investigación Biomédica en Red (CIBERCV)-Instituto de Salud Carlos III, A Coruña 15006, A Coruña, Spain
Author contributions: Vidal-Perez R and Vázquez-García R contributed equally to this work; Vidal-Perez R and Vázquez-García R designed, performed the collection of the data, edited and wrote the paper; Barge-Caballero G, Bouzas-Mosquera A, Soler-Fernandez R, Larrañaga-Moreira JM, Crespo-Leiro MG and Vazquez-Rodriguez JM contributed to the critical revision and editing of the paper.
Conflict-of-interest statement: No potential conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raquel Vázquez-García, MD, Staff Physician, Servicio de Cardiología, Complexo Hospitalario Universitario A Coruña (CHUAC), As Xubias de Arriba-84, A Coruña 15006, A Coruña, Spain. raquelvazquezgarcia@outlook.com
Received: June 25, 2020
Peer-review started: June 25, 2020
First decision: September 18, 2020
Revised: September 28, 2020
Accepted: November 17, 2020
Article in press: November 17, 2020
Published online: December 26, 2020
Processing time: 174 Days and 13.8 Hours
Peer-review started: June 25, 2020
First decision: September 18, 2020
Revised: September 28, 2020
Accepted: November 17, 2020
Article in press: November 17, 2020
Published online: December 26, 2020
Processing time: 174 Days and 13.8 Hours
Core Tip
Core Tip: Cardiac amyloidosis is a disease with a poor prognosis. However, in recent years, specific therapies have been developed. When implemented in the early stages of the disease, they are associated with an improvement in the quality of life and survival. The use of cardiac magnetic resonance, echocardiography, computed tomography and nuclear imaging techniques allows an early diagnosis. In this review, we define in detail the implication of each imaging technique in cardiac amyloidosis.